In mice, Leydig cell tumors have been induced by estrogen agonists and antagonists that may be acting directly by inducing Leydig cell proliferation and indirectly by increasing LH levels and LH receptor concentrations. The gene discussed is PLOD1; the disease is Leydig cell tumor.